Modulation of in vivo cardiac hypertrophy with insulin-like growth factor-1 and angiotensin-converting enzyme inhibitor: relationship between change in myosin isoform and progression of left ventricular dysfunction

Cardiac Hypertrophy ◽

Ventricular Dysfunction ◽

Enzyme Inhibitor ◽

Left Ventricular ◽

Converting Enzyme

Lesser Response to Angiotensin-Converting–Enzyme Inhibitor Therapy in Black as Compared with White Patients with Left Ventricular Dysfunction

New England Journal of Medicine ◽

10.1056/nejm200105033441802 ◽

2001 ◽

Vol 344 (18) ◽

pp. 1351-1357 ◽

Cited By ~ 387

Author(s):

Derek V. Exner ◽

Daniel L. Dries ◽

Michael J. Domanski ◽

Jay N. Cohn

Keyword(s):

Ventricular Dysfunction ◽

Enzyme Inhibitor ◽

Left Ventricular ◽

Inhibitor Therapy ◽

Converting Enzyme ◽

White Patients

Long-term combined therapy with losartan and an angiotensin-converting enzyme inhibitor improves functional capacity in patients with left ventricular dysfunction

Acta Cardiologica ◽

10.2143/ac.60.4.2004985 ◽

2005 ◽

Vol 60 (4) ◽

pp. 373-377 ◽

Cited By ~ 6

Author(s):

Sennur Unal DAYI ◽

Tamer AKBULUT ◽

Haldun AKGOZ ◽

Sait TERZI ◽

Nurten SAYAR ◽

...

Keyword(s):

Functional Capacity ◽

Ventricular Dysfunction ◽

Enzyme Inhibitor ◽

Combined Therapy ◽

Left Ventricular ◽

Converting Enzyme

The effect of angiotensin-converting enzyme inhibitor on exercise tolerance time in patients with left ventricular dysfunction

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(02)80652-0 ◽

2002 ◽

Vol 39 ◽

pp. 148 ◽

Cited By ~ 1

Author(s):

Jawdat Abdulla ◽

Christian Torp-Pedersen ◽

Steen Z. Abilstrøm ◽

Lars Køber

Keyword(s):

Exercise Tolerance ◽

Ventricular Dysfunction ◽

Enzyme Inhibitor ◽

Left Ventricular ◽

Converting Enzyme ◽

Tolerance Time

Effects of a New Angiotensin-Converting Enzyme Inhibitor (Idrapril) in Rats with Left Ventricular Dysfunction After Myocardial Infarction

Journal of Cardiovascular Pharmacology ◽

10.1097/00005344-199603000-00006 ◽

1996 ◽

Vol 27 (3) ◽

pp. 347-354 ◽

Cited By ~ 6

Author(s):

Gordana Jeremic ◽

Serge Masson ◽

Giuseppina Luvarà ◽

Stefano Porzio ◽

Costanza Lagrasta ◽

...

Keyword(s):

Myocardial Infarction ◽

Ventricular Dysfunction ◽

Enzyme Inhibitor ◽

Left Ventricular ◽

Converting Enzyme ◽

Converting Enzyme Inhibitor

Lesser Response to Angiotensin-Converting-Enzyme Inhibitor Therapy in Black As Compared With White Patients With Left Ventricular Dysfunction

Survey of Anesthesiology ◽

10.1097/00132586-200206000-00058 ◽

2002 ◽

Vol 46 (3) ◽

pp. 177

Author(s):

Richard A. Wiklund

Keyword(s):

Ventricular Dysfunction ◽

Enzyme Inhibitor ◽

Left Ventricular ◽

Inhibitor Therapy ◽

Converting Enzyme ◽

White Patients

?Escape? of aldosterone production in patients with left ventricular dysfunction treated with an angiotensin converting enzyme inhibitor: Implications for therapy

Cardiovascular Drugs and Therapy ◽

10.1007/bf00877755 ◽

1995 ◽

Vol 9 (1) ◽

pp. 145-149 ◽

Cited By ~ 149

Author(s):

Bertram Pitt

Keyword(s):

Ventricular Dysfunction ◽

Enzyme Inhibitor ◽

Left Ventricular ◽

Converting Enzyme ◽

Aldosterone Production

Angiotensin-converting enzyme inhibitor as a risk factor for the development of anemia, and the impact of incident anemia on mortality in patients with left ventricular dysfunction

Journal of the American College of Cardiology ◽

10.1016/j.jacc.2004.10.038 ◽

2005 ◽

Vol 45 (3) ◽

pp. 391-399 ◽

Cited By ~ 118

Author(s):

Areef Ishani ◽

Eric Weinhandl ◽

Zihong Zhao ◽

David T. Gilbertson ◽

Allan J. Collins ◽

...

Keyword(s):

Risk Factor ◽

Ventricular Dysfunction ◽

Enzyme Inhibitor ◽

Left Ventricular ◽

Converting Enzyme ◽

The Impact

Changes in left ventricular mass and volumes in patients receiving angiotensin-converting enzyme inhibitor therapy for left ventricular dysfunction after Q-wave myocardial infarction

American Heart Journal ◽

10.1053/hj.1998.v136.89405 ◽

1998 ◽

Vol 136 (2) ◽

pp. 269-275 ◽

Cited By ~ 30

Author(s):

Robert E. Foster ◽

David B. Johnson ◽

Francesco Barilla ◽

Gerald G. Blackwell ◽

Roger Orr ◽

...

Keyword(s):

Myocardial Infarction ◽

Left Ventricular Mass ◽

Ventricular Dysfunction ◽

Enzyme Inhibitor ◽

Left Ventricular ◽

Converting Enzyme ◽

Converting Enzyme Inhibitor

Lesser response to angiotensin-converting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction

ACC Current Journal Review ◽

10.1016/s1062-1458(01)00390-7 ◽

2001 ◽

Vol 10 (5) ◽

pp. 51

Author(s):

D.V Exner ◽

D.L Dries ◽

M.J Domanski ◽

J.N Cohn

Keyword(s):

Ventricular Dysfunction ◽

Enzyme Inhibitor ◽

Left Ventricular ◽

Inhibitor Therapy ◽

Converting Enzyme ◽

White Patients

Predictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy: Results from the Studies of Left Ventricular Dysfunction (SOLVD)

American Heart Journal ◽

10.1016/s0002-8703(99)70009-8 ◽

1999 ◽

Vol 138 (5) ◽

pp. 849-855 ◽

Cited By ~ 116

Author(s):

Eric L. Knight ◽

Robert J. Glynn ◽

Kevein M. McIntyre ◽

Helen Mogun ◽

Jerry Avorn

Keyword(s):

Heart Failure ◽

Renal Function ◽

Ventricular Dysfunction ◽

Enzyme Inhibitor ◽

Left Ventricular ◽

Converting Enzyme ◽

Patients With Heart Failure